
Noble E. Jarrell
Examiner (ID: 14167, Phone: (571)272-9077 , Office: P/1625 )
| Most Active Art Unit | 1699 |
| Art Unit(s) | 1625, 1699, 1622, 1624, 1609 |
| Total Applications | 1419 |
| Issued Applications | 950 |
| Pending Applications | 180 |
| Abandoned Applications | 334 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13399907
[patent_doc_number] => 20180251496
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-06
[patent_title] => OXADIAZOLE CYCLIC PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 15/760533
[patent_app_country] => US
[patent_app_date] => 2016-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11621
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15760533
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/760533 | Oxadiazole cyclic peptides | Sep 15, 2016 | Issued |
Array
(
[id] => 16816030
[patent_doc_number] => 11000831
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-11
[patent_title] => Transition metal(s) catalyst supported on nitrogen-doped mesoporous carbon and its use in catalytic transfer hydrogenation reactions
[patent_app_type] => utility
[patent_app_number] => 15/758804
[patent_app_country] => US
[patent_app_date] => 2016-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 8514
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15758804
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/758804 | Transition metal(s) catalyst supported on nitrogen-doped mesoporous carbon and its use in catalytic transfer hydrogenation reactions | Sep 11, 2016 | Issued |
Array
(
[id] => 11512929
[patent_doc_number] => 20170080001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-23
[patent_title] => 'SILYL MONOMERS CAPABLE OF MULTIMERIZING IN AN AQUEOUS SOLUTION, AND METHODS OF USING SAME'
[patent_app_type] => utility
[patent_app_number] => 15/247539
[patent_app_country] => US
[patent_app_date] => 2016-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 39300
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15247539
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/247539 | Silyl monomers capable of multimerizing in an aqueous solution, and methods of using same | Aug 24, 2016 | Issued |
Array
(
[id] => 15573967
[patent_doc_number] => 10577350
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-03
[patent_title] => Crystalline forms of (R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide
[patent_app_type] => utility
[patent_app_number] => 15/755854
[patent_app_country] => US
[patent_app_date] => 2016-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 6205
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15755854
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/755854 | Crystalline forms of (R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide | Aug 24, 2016 | Issued |
Array
(
[id] => 13357123
[patent_doc_number] => 20180230101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-16
[patent_title] => PROCESS FOR THE PREPARATION OF 5-AMINO-QUINOLIN-2(1H)-ONES AND THEIR TAUTOMER FORMS 5-AMINO-QUINOLIN-2-OLS
[patent_app_type] => utility
[patent_app_number] => 15/750449
[patent_app_country] => US
[patent_app_date] => 2016-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14334
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15750449
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/750449 | PROCESS FOR THE PREPARATION OF 5-AMINO-QUINOLIN-2(1H)-ONES AND THEIR TAUTOMER FORMS 5-AMINO-QUINOLIN-2-OLS | Jul 31, 2016 | Abandoned |
Array
(
[id] => 13314123
[patent_doc_number] => 20180208598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-26
[patent_title] => PYRROLO[2,3-d]PYRIMIDINE COMPOUND OR SALT THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/746208
[patent_app_country] => US
[patent_app_date] => 2016-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18496
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15746208
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/746208 | Pyrrolo[2,3-d]pyrimidine compound or salt thereof | Jul 28, 2016 | Issued |
Array
(
[id] => 13793231
[patent_doc_number] => 20190010154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-10
[patent_title] => FACTOR XIA MACROCYCLE INHIBITORS BEARING A NON-AROMATIC P2' GROUP
[patent_app_type] => utility
[patent_app_number] => 15/747867
[patent_app_country] => US
[patent_app_date] => 2016-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36046
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15747867
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/747867 | Factor XIa macrocycle inhibitors bearing a non-aromatic P2' group | Jul 27, 2016 | Issued |
Array
(
[id] => 15784817
[patent_doc_number] => 10626115
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-21
[patent_title] => Fused pyrimidinone and triazinone derivatives containing bridged nitrogen, their process of preparation and their therapeutic uses as antifungal and/or antiparasitic agents
[patent_app_type] => utility
[patent_app_number] => 15/748905
[patent_app_country] => US
[patent_app_date] => 2016-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 6
[patent_no_of_words] => 11573
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15748905
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/748905 | Fused pyrimidinone and triazinone derivatives containing bridged nitrogen, their process of preparation and their therapeutic uses as antifungal and/or antiparasitic agents | Jul 21, 2016 | Issued |
Array
(
[id] => 12861982
[patent_doc_number] => 20180179168
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-28
[patent_title] => SUBSTITUTED PHENYLOXAZOLIDINONES FOR ANTIMICROBIAL THERAPY
[patent_app_type] => utility
[patent_app_number] => 15/738503
[patent_app_country] => US
[patent_app_date] => 2016-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30843
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15738503
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/738503 | Substituted phenyloxazolidinones for antimicrobial therapy | Jul 14, 2016 | Issued |
Array
(
[id] => 13328359
[patent_doc_number] => 20180215717
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => FUSED IMIDAZOLES AS MIDH1 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 15/746352
[patent_app_country] => US
[patent_app_date] => 2016-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24799
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15746352
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/746352 | Fused imidazoles as mIDH1 inhibitors | Jul 13, 2016 | Issued |
Array
(
[id] => 13790603
[patent_doc_number] => 20190008840
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-10
[patent_title] => Bis-amines, Compositions, and Uses Related to CXCR4 Inhibition
[patent_app_type] => utility
[patent_app_number] => 15/745291
[patent_app_country] => US
[patent_app_date] => 2016-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21477
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15745291
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/745291 | Bis-amines, compositions, and uses related to CXCR4 inhibition | Jul 12, 2016 | Issued |
Array
(
[id] => 17497554
[patent_doc_number] => 11286246
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-29
[patent_title] => Pro-drugs and related methods
[patent_app_type] => utility
[patent_app_number] => 15/745714
[patent_app_country] => US
[patent_app_date] => 2016-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 5717
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 331
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15745714
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/745714 | Pro-drugs and related methods | Jul 12, 2016 | Issued |
Array
(
[id] => 13972807
[patent_doc_number] => 10215751
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-26
[patent_title] => Carboxy X rhodamine analogs
[patent_app_type] => utility
[patent_app_number] => 15/204664
[patent_app_country] => US
[patent_app_date] => 2016-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 56
[patent_no_of_words] => 21665
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 318
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15204664
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/204664 | Carboxy X rhodamine analogs | Jul 6, 2016 | Issued |
Array
(
[id] => 13357091
[patent_doc_number] => 20180230085
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-16
[patent_title] => 1,4-DISUBSTITUTED IMIDAZOLE DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 15/507188
[patent_app_country] => US
[patent_app_date] => 2016-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27280
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15507188
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/507188 | 1,4-disubstituted imidazole derivative | Jun 20, 2016 | Issued |
Array
(
[id] => 11353944
[patent_doc_number] => 20160372684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-22
[patent_title] => 'DONOR-ACCEPTOR NANOHOOP COMPOUNDS AND METHODS OF MAKING AND USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 15/187644
[patent_app_country] => US
[patent_app_date] => 2016-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 17377
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15187644
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/187644 | Donor-acceptor nanohoop compounds and methods of making and using the same | Jun 19, 2016 | Issued |
Array
(
[id] => 14910969
[patent_doc_number] => 10426784
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-01
[patent_title] => Imidazodiazepine compound
[patent_app_type] => utility
[patent_app_number] => 15/737564
[patent_app_country] => US
[patent_app_date] => 2016-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12065
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15737564
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/737564 | Imidazodiazepine compound | Jun 16, 2016 | Issued |
Array
(
[id] => 16941058
[patent_doc_number] => 11053279
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-06
[patent_title] => Methods for the site-selective coupling of a first agent to a second agent
[patent_app_type] => utility
[patent_app_number] => 15/737769
[patent_app_country] => US
[patent_app_date] => 2016-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 59
[patent_no_of_words] => 27556
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15737769
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/737769 | Methods for the site-selective coupling of a first agent to a second agent | Jun 15, 2016 | Issued |
Array
(
[id] => 14454127
[patent_doc_number] => 10323015
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-18
[patent_title] => Leveler, leveler composition and method for electrodeposition of metals in microelectronics
[patent_app_type] => utility
[patent_app_number] => 15/181469
[patent_app_country] => US
[patent_app_date] => 2016-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 51
[patent_no_of_words] => 13370
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 202
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15181469
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/181469 | Leveler, leveler composition and method for electrodeposition of metals in microelectronics | Jun 13, 2016 | Issued |
Array
(
[id] => 12212105
[patent_doc_number] => 09908900
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-06
[patent_title] => 'Methods for forming protected organoboronic acids'
[patent_app_type] => utility
[patent_app_number] => 15/168457
[patent_app_country] => US
[patent_app_date] => 2016-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 15
[patent_no_of_words] => 18041
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15168457
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/168457 | Methods for forming protected organoboronic acids | May 30, 2016 | Issued |
Array
(
[id] => 11311675
[patent_doc_number] => 20160347784
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-01
[patent_title] => 'NOVEL NUCLEIC ACID PRODRUGS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/167669
[patent_app_country] => US
[patent_app_date] => 2016-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 56228
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15167669
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/167669 | Nucleic acid prodrugs and methods of use thereof | May 26, 2016 | Issued |